# OXYGEN DEVELOPMENT, L.L.C. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/oxygen-development-llc/024c27c1-6cfa-4c7b-9daf-9005cbf515b7

> Inspection records and compliance data for OXYGEN DEVELOPMENT, L.L.C. in Palm Springs, Florida. Access full analysis and detailed observations.

---

## Details

- Name: OXYGEN DEVELOPMENT, L.L.C.
- FEI Number: 3009461317
- City: Palm Springs
- State: Florida
- Country Name: United States
- Address Line 1: 1525 S Congress Ave
- Zip Code: 33406

## Related Documents

- [483 - OXYGEN DEVELOPMENT, L.L.C. - 2025-09-11](https://www.globalkeysolutions.net/records/483/oxygen-development-llc/b36d2d36-735e-40c3-a882-a4a6d8fdb1ce) — source: FDA, date: September 11, 2025
- [FDA Inspection 1250745 - OXYGEN DEVELOPMENT, L.L.C. - 2025-09-11](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/951e75e0-9474-4220-8341-ba8cd5ae30a1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2025
- [FDA Inspection 1042460 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-19](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/04fc63c5-43ea-4896-abfe-236d6dad1098) — classification: No Action Indicated (NAI), source: FDA, date: January 19, 2018
- [483 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.globalkeysolutions.net/records/483/oxygen-development-llc/8a8320a3-2cff-4b58-955c-fef5cb2a96d1) — source: FDA, date: January 17, 2018
- [FDA Inspection 1039561 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/9deefb7a-9015-45ac-b4cf-eb9d000bd06d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2018
- [FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/83b1d754-fed3-4709-8a26-932a779f6a8b) — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2013
- [FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/229a4661-b57a-4cd5-8d1c-bc1af2884b80) — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2013
- [FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/0cf9746a-9561-4d22-970a-0f4837f177ff) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2013
- [FDA Inspection 824681 - OXYGEN DEVELOPMENT, L.L.C. - 2013-03-29](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/71aada83-67bb-4e02-ae37-670289f578ea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2013
- [FDA Inspection 824681 - OXYGEN DEVELOPMENT, L.L.C. - 2013-03-29](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/362052f5-8eba-41f1-b5f2-8a6fcde28af7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2013
- [FDA Inspection 775347 - OXYGEN DEVELOPMENT, L.L.C. - 2012-05-11](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/f1c2a2c7-8908-4fa2-bee4-d757bc3ea54d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2012
- [FDA Inspection 584937 - OXYGEN DEVELOPMENT, L.L.C. - 2009-05-29](https://www.globalkeysolutions.net/records/fda_inspections/oxygen-development-llc/85f85599-63b0-4e53-abdb-9a6413d27c1f) — classification: No Action Indicated (NAI), source: FDA, date: May 29, 2009

## Related Companies

- [Aphena Pharma Solutions-Maryland LLC](https://www.globalkeysolutions.net/companies/aphena-pharma-solutions-maryland-llc/97893fd6-3370-41f2-95ce-17928ab057e2)
- [Quality Packaging Specialists International, LLC](https://www.globalkeysolutions.net/companies/quality-packaging-specialists-international-llc/74a9861b-efac-463e-b6f9-bd1e22db674a)
- [AML Riverside, LLC](https://www.globalkeysolutions.net/companies/aml-riverside-llc/1e839f8a-1cf4-48cd-90e1-62e3a2de0ca6)
- [Lannett Company Inc.](https://www.globalkeysolutions.net/companies/lannett-company-inc/d4d7f04f-0ec5-4f5a-868b-d48963202cc8)
- [Lusomedicamenta Sociedade Tecnica Farmaceutica S.A](https://www.globalkeysolutions.net/companies/lusomedicamenta-sociedade-tecnica-farmaceutica-sa/f5b2b06c-020e-4078-9766-b6b28bc61e65)
- [TriRx Huntsville Pharmaceutical Services, LLC](https://www.globalkeysolutions.net/companies/trirx-huntsville-pharmaceutical-services-llc/bdf3220b-2a57-4125-b4ef-af4d1d9c9fa8)
- [Hill Dermaceuticals, Inc.](https://www.globalkeysolutions.net/companies/hill-dermaceuticals-inc/f3bca28c-18cf-4743-8a40-705b02d4cc9c)
- [Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.](https://www.globalkeysolutions.net/companies/istituto-biochimico-italiano-giovanni-lorenzini-spa/15ae51d8-a4ba-42a6-9100-2d04641f2514)
- [PTI Georgia, LLC](https://www.globalkeysolutions.net/companies/pti-georgia-llc/a1dea629-43b4-4dda-963c-1b320b0311a5)
- [Aquestive Therapeutics](https://www.globalkeysolutions.net/companies/aquestive-therapeutics/1f8e3576-370b-4aa2-b1d2-6d0faa6c3631)

## Related Officers

- [Jennifer L. Huntington](https://www.globalkeysolutions.net/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)
- [Alan A. Rivera](https://www.globalkeysolutions.net/people/alan-a-rivera/4bec02c3-c62e-4b3a-a6ab-02c3386549bf)